0 NASDAQ Companies - November 30, 2018Himax Chairman Announces Share Purchase PlanTAINAN, Taiwan, Nov. 30, 2018 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and […]Read More
0 Canadian Stock Exchange News - November 30, 2018Squire Enters Into Non-Binding Letter of Intent and Exclusive Negotiations Regarding Acquisition of CoinGeek.com and 1.0 Million TH/s of Mining Assets, Forming the Largest Public Crypto Mining Company, and Name Change to “CoinGeek Technologies Ltd.”VANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) — Squire Mining Ltd. (CSE:SQR | FWB:9SQ | OTCQB:SQRMF) (“Squire”) is pleased […]Read More
0 Canadian Stock Exchange News - November 30, 2018MGX Minerals Reports Up to 100% SiO2 at Gibraltar and 99.9% SiO2 at Wonah Silica Properties; Completes 2nd Drill Hole at GibraltarVANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) — MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: […]Read More
0 TSX Venture News - November 30, 2018GreenPower Announces Results for the Second QuarterVANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) — GreenPower Motor Company Inc. (TSXV: GPV) (OTCQX: GPVRF) (“GreenPower” or the […]Read More
0 NYSE Companies - November 30, 2018Dolby Laboratories Honored with American Cinematheque’s 2018 Sid Grauman AwardLOS ANGELES, Nov. 29, 2018 (GLOBE NEWSWIRE) — Dolby Laboratories received American Cinematheque’s 2018 Sid Grauman Award, an honor bestowed […]Read More
0 NASDAQ Companies - November 30, 2018Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary AngioedemaIntended for Global Audience Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema […]Read More
0 TSX Venture News - November 30, 2018Galantas Receives Agreements for Maximum Amount in Private PlacementTORONTO, Nov. 30, 2018 (GLOBE NEWSWIRE) — Galantas Gold Corporation (the “Company” or “Galantas”), the AIM and TSX Venture Exchange […]Read More
0 NASDAQ Companies - November 30, 2018Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101Topline data from alloSHRINK trial are expected in second half of 2019 Company regains full development and commercialization rights to […]Read More
0 Canadian Stock Exchange News - November 29, 2018Lexington Announces Q3 2018 Financial Results and Non-Brokered Private PlacementNOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER […]Read More
0 NASDAQ Companies - November 29, 2018iQIYI Prices Offering of US$650 Million Convertible Senior NotesBEIJING, Nov. 29, 2018 (GLOBE NEWSWIRE) — iQIYI, Inc. (NASDAQ: IQ) (“iQIYI” or the “Company”), an innovative market-leading online entertainment […]Read More